Bactericidal activity of ceragenin CSA-13, CSA-44 and CSA-131 against bacteria causing bloodstream infections
Frontiers in Microbiology · 01.10.2025 · 16
DOI: 10.3389/fmicb.2025.1640392 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 01.10.2025. Verfasst von Angelika Mańkowska und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Institute of Medical Science, Collegium Medicum, Jan Kochanowski University in Kielce, Kielce, Poland. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The constantly growing resistance of bacteria causing bloodstream infections and the lack of alternative antibiotics generate the need to develop new therapeutic strategies. In this study, the antibacterial properties of synthetic cholic acid derivatives ceragenins CSA-13, CSA-44 and CSA-131, custom-synthesized peptides human cathelicidin LL-37 peptide, synthetic WLBU2 peptide, and antimicrobial VFR12 peptide of human thrombin origin were evaluated to determine their potentials as therapeutic agents for bloodstream infections.
Methods
Minimum inhibitory concentrations/minimum bactericidal concentrations (MIC/MBC) against clinical bacterial strains were measured and compared with activity of clinically used antibiotics colistin and vancomycin. Therapeutic potentials of the tested agents were assessed in the presence of 50% blood plasma, and their hemolytic properties were determined using human red blood cells (RCB). Additionally, the antimicrobial activity of CSA-13 against selected clinical strains was assessed using a killing assay. Plasma cytokine levels were determined, and endothelial cell confluent monolayer permeability was assessed using the FITC-dextran and measurement of transepithelial electrical resistance (TEER).
Results
Under experimental conditions mimicking blood environment, ceragenins display higher antimicrobial activity compared to the cationic peptides regardless of the bacterial species. The presence of blood plasma slightly decreases the effect of ceragenins but does not significantly affect their antibacterial properties or their hemolytic activity, especially in case of ceragenin CSA-13. Furthermore, ceragenins at bactericidal concentrations do not induce hemolysis of red blood cells. CSA-13 dose-dependently regulates the permeability of human umbilical vein endothelial cells (HUVECs) monolayers as well as affects the secretion of cytokines, which may indicate its ability to modulate immune responses.
Conclusion
Results presented herein demonstrate the antibacterial activity of ceragenins against clinical strains of bacteria isolated from blood, their influence on the immune system and the integrity of the endothelial cell monolayer. Further studies are necessary to understand the cell signaling pathway governing these effects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Institute of Medical Science, Collegium Medicum, Jan Kochanowski University in Kielce, Kielce, Poland.
- Department of Medical Microbiology and Nanobiomedical Engineering, Medical University of Białystok, Białystok, Poland.
- Institute of Medical Science, Collegium Medicum, Jan Kochanowski University in Kielce, Kielce, Poland.
- Department of Otolaryngology, Head and Neck Surgery, Holy-Cross Oncology Center of Kielce, Kielce, Poland.
- Independent Laboratory of Nanomedicine, Medical University of Białystok, Białystok, Poland.
- Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, United States.
Zitieren
APA
Mańkowska, A., Paprocka, P., Suprewicz, Ł., Lesiak, A., Fortunka, K., Król, G., Spałek, J., Okła, S., Durnaś, B., Daniluk, T., Piktel, E., Savage, P. B., & Bucki, R. (2025). Bactericidal activity of ceragenin CSA-13, CSA-44 and CSA-131 against bacteria causing bloodstream infections. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1640392
Vancouver
Mańkowska A, Paprocka P, Suprewicz Ł, Lesiak A, Fortunka K, Król G, et al. Bactericidal activity of ceragenin CSA-13, CSA-44 and CSA-131 against bacteria causing bloodstream infections. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1640392
BibTeX
@article{Makowska2025,
author = {Mańkowska, Angelika and Paprocka, Paulina and Suprewicz, Łukasz and Lesiak, Agata and Fortunka, Kamila and Król, Grzegorz and Spałek, Jakub and Okła, Sławomir and Durnaś, Bonita and Daniluk, Tamara and Piktel, Ewelina and Savage, Paul B and Bucki, Robert},
title = {Bactericidal activity of ceragenin CSA-13, CSA-44 and CSA-131 against bacteria causing bloodstream infections},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1640392}
}
EUVIMED